Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 201 - 250 out of 10,961

Document Document Title
WO/2016/001075A1
The invention relates to N-(1-methyltetrazol-5-yl)benzoic acid amides of the general formula (I) as herbicides. In formula (I) X, Z and R represent radicals such as alkyl and cycloalkyl.  
WO/2016/001390A1
The present invention relates to a compound of formula (I), or a tautomer and/or a pharmaceutically acceptable salt thereof Formula (I), and its uses to treat a disorder associated with protein misfolding stress and in particular with an...  
WO/2016/001074A1
The invention relates to benzoic acid amides of general formula (I) as herbicides. In formula (I) X, Z and R represent radicals such as alkyl and cycloalkyl. Q represents a 5-membered heterocycle.  
WO/2015/198850A1
Provided is a method for producing a compound represented by formula (2-b), which is useful as an intermediate for producing agricultural chemicals. The method includes a step for obtaining a compound represented by formula (2-a) by oxid...  
WO/2015/194293A1
This lubricant contains a protic ionic liquid having a conjugate acid (B+) and a conjugate base (X-), the ionic liquid is represented by general formula (1), and the conjugate base is one of the conjugate base of sulfonic acid, the conju...  
WO/2015/181249A1
The present invention relates to processes for preparing β-aminosulfone compounds. The provided compounds are useful intermediates in the preparation of sulfone group containing isoindoline-based compounds, in particular apremilast.  
WO/2015/026990A8
The present disclosure is generally directed to compositions and methods for treating diseases that are ameliorated by the inhibition of CYP26 mediated retinoic acid metabolism. The compositions comprise compounds of formula (I). A repre...  
WO/2015/157927A1
Disclosed is a new florfenicol synthesizing method. The method synthesizes florfenicol products meeting requirements of the Drug Administration by a series of combinations of cyclization, selective reduction, fluorinated open ring, depro...  
WO/2015/157313A1
Described herein, inter alia, are compositions and methods useful for inhibiting fatty acid amide hydrolase.  
WO/2015/145371A1
The present invention relates to a compound of formula I, or an isotopic form, stereoisomer, a tautomer, a pharmaceutically acceptable salt, a solvate, a polymorph, a prodrug, N-oxide or S-oxide thereof; and processes for their preparati...  
WO/2011/088209A3
This present disclosure is directed to novel prodrugs of activated vitamin D3 compounds. The prodrugs can be designed to have one or more beneficial properties, such as selective inhibition of the enzyme CYP24, low calcemic activity, and...  
WO/2015/131200A1
Small molecule xanthine oxidase inhibitors, speifically substituted benzaldehydes including dihydroxy and trihydroxy benzaldehydes having therapeutic utility in the treatment of gout and hyperuricemia are provided. Pharmaceutical composi...  
WO/2015/013187A8
The present invention relates to hydroxamate compounds and pharmaceutical compositions that are useful for treating and/or preventing metabolic inflammation mediated diseases such as diabetes, obesity, hypertension, dyslipidemia, a neuro...  
WO/2015/104343A1
It relates to spirocyclic compounds of formula (I), or pharmaceutically or veterinary acceptable salts thereof, or any stereoisomers either of the compounds of formula (I) or of their pharmaceutically or veterinary acceptable salts, wher...  
WO/2015/066135A3
Metal ligand-containing prepolymers, compositions containing metal ligand-containing prepolymers, methods of synthesizing metal ligand-containing prepolymers and the use of metal ligand-containing prepolymers in aerospace sealant applica...  
WO/2015/103507A1
Described are RORϒ modulators of the formula (I), or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof, wherein all substituents are defined herein. Also provided are pharmaceutical compositions ...  
WO/2015/103508A1
Described are RORγ modulators of the formula (I), or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof, wherein all substituents are defined herein. Also provided are pharmaceutical compositions ...  
WO/2015/100225A1
The present invention provides sulfur- or selenium-containing compounds comprising hydrophobic moieties and ethoxylated ester or ethoxylated amide moieties such that the compounds have surfactant properties. Also provided are methods for...  
WO/2015/096226A1
A thermally activated delayed fluorescence material, synthetic process thereof and OLED device using same. The structure of the thermal activation delayed fluorescence material is represented by formula (1), wherein Ar1 is the same as or...  
WO/2015/087352A1
The present patent discloses a novel, efficient and transition-metal-free room temperature single step process for synthesis of aryl sulfones and substituted aryl sulfones starting from aryl substrates.  
WO/2015/087834A1
The objective of the present invention is to provide a polyester resin composition which is free from the generation of an irritating gas in the production processes, and which is not increased in the viscosity of a polyester resin even ...  
WO/2015/082533A1
The present invention relates to compounds according to Formula I: Wherein: A11 - A14 are N or CR11, CR12, CR13, CR14, respectively, with the proviso that no more than two of the four positions A can be simultaneously N; R1 is C(1-6)alky...  
WO/2015/078802A1
The present invention relates to compounds of general formula (I), wherein the groups R1, R2, R3, X, m and n are defined as in claim 1, wich have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate ...  
WO/2015/081188A1
The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and an omega-(arylsulfonyl)alkylnitrile compound, or a pharmaceutically acceptable salt thereof. The present invention is ...  
WO/2015/080217A1
A purpose of the present invention is to provide a coloring resin composition which has high color purity and satisfactory light resistance, and which develops a high contrast. Another purpose of the present invention is to provide: a co...  
WO/2015/076395A1
The present invention addresses the problem of providing: an acid- and radical-generating agent which has high sensitivity to an active energy ray having a wavelength of about 300 to 450 nm, can exhibit both high acid-generating ability ...  
WO/2015/074281A1
The present application relates to rigosertib salt and a crystal form thereof. Compared with existing rigosertib salt, the rigosertib salt and the crystal form thereof in the present application has advantages on crystallinity, crystal h...  
WO/2015/072463A1
In the production of crops in agriculture, horticulture, and the like, damage by destructive insects is still great, and the development of novel agricultural/horticultural insecticides is desired due to the occurrence of destructive ins...  
WO/2015/026990A3
The present disclosure is generally directed to compositions and methods for treating diseases that are ameliorated by the inhibition of CYP26 mediated retinoic acid metabolism. The compositions comprise compounds of formula (I). A repre...  
WO/2015/064584A1
The present invention produces various triarylmethane compounds at a high yield and by means of few steps by means of reacting a diaryl methyl aryl sulfone compound represented by the formula CHAr1Ar2SO2Ar (where Ar1, Ar2, and Ar are sub...  
WO/2015/062103A1
Disclosed are a refining method for 2-nitro-4-methylsulfonyl benzoic acid and an intermediate thereof. The method comprises the following steps of: synthesizing an intermediate organic ammonium salt (III) in an organic solvent using a cr...  
WO/2015/054008A1
The present invention is directed to 4-methylsulfonyl-2-butenenitrile, or a pharmaceutically acceptable salt, an isomer, or isomers thereof. The present invention is also directed to a pharmaceutical composition comprising a pharmaceutic...  
WO/2015/050878A1
The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and 3-benzylsulfonylpropionitrile, or a pharmaceutically acceptable salt thereof. The present invention is directed to a m...  
WO/2015/051141A1
Methods for preparing fluorinated sulfides and fluorinated sulfones are described. To prepare a fluorinated sulfides, a sulfur-containing reactant represented by the formula: R1SM or M2S, wherein R1 is a C1 to C10 alkyl or fluoroalkyl, S...  
WO/2015/032328A1
The present invention relates to an indane derivative, a preparation method therefor, and a pharmaceutical application thereof. Specifically, the present invention relates to a compound shown in formula (I), or a stereoisomer thereof, an...  
WO/2015/033936A1
The present invention relates to a polyarylene sulfide resin manufacturing method comprising: a process for obtaining a poly(arylene sulfonium salt) having specified constituent units by reacting a sulfoxide represented by general formul...  
WO/2015/006728A3
The present invention relates to methods and reagents for use in site-selective modification of proteins having lysine residues with functionalized peptides using a chemoenzymatic microbial transglutaminase-mediated reaction. The functio...  
WO/2015/028938A1
The invention relates to naphthalene compounds of Formula (I) and their pharmaceutically acceptable salts, wherein the substituents are as described herein, and their use in medicine for the treatment of diseases, disorders associated wi...  
WO/2015/025960A1
Provided are: a compound having high activity against harmful organisms; a harmful organism control agent comprising the compound; and a method for controlling harmful organisms by applying the compound. A phenoxyalkylbenzamide-type comp...  
WO/2015/025826A1
The purpose of the present invention is to provide: a novel substituted phenyl ether compound which has a control effect against pests; and a pest control agent which contains this substituted phenyl ether compound as an active ingredien...  
WO/2015/022631A1
The invention relates to compounds of Formula (I) and their pharmaceutically acceptable salts, wherein the substituents are as described herein, and their use in medicine for the treatment of diseases, disorders associated with the modul...  
WO/2015/010655A1
Triadic fused cyclic carboxylic acids derivatives, preparation method therefor and pharmaceutical use thereof, particularly relating to compounds represented by general formula (I), stereoisomers, hydrates, solvates, metabolites, eutecti...  
WO/2015/013187A1
The present invention relates to hydroxamate compounds and pharmaceutical compositions that are useful for treating and/or preventing metabolic inflammation mediated diseases such as diabetes, obesity, hypertension, dyslipidemia, a neuro...  
WO/2015/011334A1
The invention relates to the use of compounds comprising a molecule of lipid origin and a vinyl sulfone group as an immunological adjuvant. The lipid molecule binds to an antigen in order to form a lipopeptide that acts as a vaccine. The...  
WO/2003/063762A3
The present invention discloses a process for the synthesis of reverse hydroxamate matrix metalloproteinase (MMP) inhibitors.  
WO/2014/205091A1
The use of Michael addition curing chemistries in compositions comprising sulfur-containing polymers such as polythioethers and polysulfides useful in aerospace sealant applications are disclosed. Sulfur-containing adducts comprising ter...  
WO/2014/147182A3
The present invention relates to substituted N-biphenyl-3-acetylamino-benzamides and N-[3-(acetylamino)phenyl]-biphenyl-carboxamides of general formula (I) as described and defined herein, to methods of preparing said compounds, to inter...  
WO/2014/138518A3
Disclosed herein are bisarylmethylthioacetamides and bisarylmethylthioethylamines useful as inhibitors of monoamine transporters. The compounds are potent and/or selective inhibitors of dopamine (DA), serotonin (5-HT), and/or norepinephr...  
WO/2014/178309A1
 The present invention provides a method for purifying dimethyl sulfoxide economically and at good yield so as to satisfy the specifications of the United States Pharmacopoeia and reduce odor. The method is characterized in that a solu...  
WO/2014/178389A1
Provided is a new compound having glycogen synthase activation potency, high muscular transition, minimal activation of receptor PPAR, and a high degree of safety. Provided is a compound represented by the following general formula, or a...  

Matches 201 - 250 out of 10,961